Undergraduate Study Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Division of Plastic Surgery, Department of Surgery, Cipto Mangunkusumo Hospital/Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
J Cosmet Dermatol. 2022 May;21(5):1913-1919. doi: 10.1111/jocd.14385. Epub 2021 Oct 7.
INTRODUCTION: Adipose-derived stem cells (ASCs) have recently gained researchers' interest as a solution to various diseases and conditions, including hypertrophic scar. This literature review aims to elucidate ASCs as a potential solution to alleviate hypertrophic scar in human subjects. METHODS: Literature search was done in databases which includes PubMed, MEDLINE, and ProQuest using terms 'adipose derived stem cells', 'adipose cells', 'fat graft', 'fat grafting', 'autologous fat graft', 'fat injection', 'lipofilling', 'scar management', 'scar treatment', 'burn scar', and 'wound management'. The included articles which were published during year 2000-November 2020 must describe the use of ASCs or fat grafting or lipofilling as an attempt to alleviate hypertrophic scar. REMARKS: Clinically, ASCs improve hypertrophic scars in terms of scar color, elasticity, texture, thickness, and size. Histologically, ASCs promotes healthy tissue regeneration, reduction in fibroblasts, and reorganisation of collagen, resembling those of normal skin. In terms of molecular aspects, ASCs alleviates hypertrophic scars through direct differentiation and paracrine mechanisms. CONCLUSION: Adipose-derived stem cells, emerge to be a potential solution for alleviating hypertrophic scar, as demonstrated in various studies. However, there has been no studies conducted in human subjects to investigate the effect of ASCs on hypertrophic scar.
简介:脂肪来源的干细胞 (ASCs) 最近引起了研究人员的兴趣,可作为治疗各种疾病和病症的一种方法,包括增生性瘢痕。本文献综述旨在阐明 ASCs 作为减轻人类增生性瘢痕的一种潜在解决方案。
方法:使用术语“脂肪来源的干细胞”、“脂肪细胞”、“脂肪移植”、“脂肪移植术”、“自体脂肪移植”、“脂肪注射”、“脂肪填充”、“瘢痕管理”、“瘢痕治疗”、“烧伤瘢痕”和“伤口管理”,在 PubMed、MEDLINE 和 ProQuest 数据库中进行文献检索。纳入的文章必须在 2000 年至 2020 年 11 月期间发表,描述使用 ASCs 或脂肪移植术或脂肪填充术来尝试减轻增生性瘢痕。
评论:临床上,ASCs 可改善瘢痕的颜色、弹性、质地、厚度和大小等方面的增生性瘢痕。组织学上,ASCs 促进健康组织再生,减少成纤维细胞,并重新组织胶原,类似于正常皮肤。从分子方面来看,ASCs 通过直接分化和旁分泌机制减轻增生性瘢痕。
结论:脂肪来源的干细胞作为减轻增生性瘢痕的潜在解决方案已经得到了证实,但目前还没有研究在人体中研究 ASCs 对增生性瘢痕的影响。
Stem Cell Res Ther. 2018-3-9
Cell Tissue Bank. 2021-3
Rev Assoc Med Bras (1992). 2016-12
Cells. 2024-8-20
Cytotherapy. 2019-9-17
Bioact Mater. 2024-9-11
Int J Mol Sci. 2024-4-25
Front Cell Dev Biol. 2022-1-6